In our study however, GOLGA4 was downregulated in PBMCs of ME/CFS patients, potentially causing impaired TNF secretion and subsequently an impaired immune response to inflammation. Here, GOLGA4 is linked to myalgic encephalomeyelitis/chronic fatigue syndrome.